Changes in Red Blood Cell Transfusion Burden with Luspatercept Versus Epoetin Alfa in Patients with Lower-Risk Myelodysplastic Syndromes in the Phase 3, Open-Label, Randomized, Controlled COMMANDS TrialGuillermo Garcia‐Manero, Uwe Platzbecker, Valeria Santini et al.|Blood|2024Cited by 1